Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine for Postoperative Anxiety in Elderly Patients
NCT05640427Completed
- Sponsor
- The First Hospital of Qinhuangdao
- Start
- Mar 2022
- Primary completion
- Mar 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of dexmedetomidine in anxiety disorder (3 arms), sponsored by The First Hospital of Qinhuangdao. Primary endpoints: Incidence of anxiety at one day after surgery and Incidence of anxiety at three days after surgery. Started Mar 2022; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
anxiety disorder
Beyond the preview
Go deeper on NCT05640427.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05640427.